Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvimopan for Ileus After Spinal Fusion
NCT02218190Completed
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative ileus (POI) comparing Alvimopan with Placebo (2 arms). Primary endpoints: Recovery of Bowel Function at 14 days and Length of Hospital Stay at 14 days. Started Aug 2014; status: completed.
02
Drugs
alvimopan
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT02218190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218190.